Pharmaceutical companies navigate a new peptide policy
The policy change put verified manufacturing, purity, testing, and patient safety at the center of supplier review. In October 2026, the Department of Health and Human Services introduced a…
The policy change put verified manufacturing, purity, testing, and patient safety at the center of supplier review. In October 2026, the Department of Health and Human Services introduced a…
WhatsApp us